cyclophilin cup peptidylprolyl mistral isomers npias act virus factor mani bacteria include staphylococcu aureus enzyme active inhibit cyclosporin csa immunosuppress drug precise determine unfold meghan domain structure investing chime rcid use various probe limit proteolysi consent analysis proteolyt fragment india compose one short flexible tail termini end also show ureainduc rcypcsa complete revert price via synthesis least stable intermedia secondary tertiary appear similar correspond native protein covers hydrophobic surface area intermedia compare le analyst reveal loss bind thermodynamic static significantly increase present recommend could employ screen new derive future 